Literature DB >> 9777464

Activated charcoal microcapsules and their applications.

T Chandy1, C P Sharma.   

Abstract

Activated charcoal, long known to the ancients as a substance of therapeutic value in a variety of maladies, has recently been "rediscovered" to be of great value in medical applications. Activated charcoal hemoperfusion is effective in blood purification for removal of various circulating toxic materials and waste metabolites, directly. However, particulate release and platelet adhesion prevent its continued clinical use. Polymeric coatings or microencapsulation of charcoal within polymers have improved their blood compatibility. Chitosan encapsulated activated charcoal (ACCB) beads have been extensively investigated in our group for the removal of various toxins such as urea, creatinine, uric acid, bilirubin, etc. This article highlights various methods of microencapsulation procedures of activated charcoal and the importance of this novel material for a variety of biomedical applications. Further, this review provides an insight to the future perspectives for using them in clinical practice.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9777464     DOI: 10.1177/088532829801300204

Source DB:  PubMed          Journal:  J Biomater Appl        ISSN: 0885-3282            Impact factor:   2.646


  4 in total

1.  Effect of Sea Tangle (Laminaria japonica) and Charcoal Supplementation as Alternatives to Antibiotics on Growth Performance and Meat Quality of Ducks.

Authors:  M M Islam; S T Ahmed; Y J Kim; H S Mun; Y J Kim; C J Yang
Journal:  Asian-Australas J Anim Sci       Date:  2014-02       Impact factor: 2.509

2.  Effects of Enriched Charcoal as Permanent 0.2% Feed-Additive in Standard and Low-Protein Diets of Male Fattening Turkeys: An On-Farm Study.

Authors:  Katharina Hinz; Jenny Stracke; Jule Katrin Schättler; Nicole Kemper; Birgit Spindler
Journal:  Animals (Basel)       Date:  2019-08-08       Impact factor: 2.752

3.  A Bifunctional Adsorber Particle for the Removal of Hydrophobic Uremic Toxins from Whole Blood of Renal Failure Patients.

Authors:  Marieke Sternkopf; Sven Thoröe-Boveleth; Tobias Beck; Kirsten Oleschko; Ansgar Erlenkötter; Ulrich Tschulena; Sonja Steppan; Thimoteus Speer; Claudia Goettsch; Vera Jankowski; Joachim Jankowski; Heidi Noels
Journal:  Toxins (Basel)       Date:  2019-07-03       Impact factor: 4.546

4.  Extracorporeal Removal of Thermosensitive Liposomal Doxorubicin from Systemic Circulation after Tumor Delivery to Reduce Toxicities.

Authors:  Anjan Motamarry; A Marissa Wolfe; Krishna K Ramajayam; Sanket Pattanaik; Thomas Benton; Yuri Peterson; Pegah Faridi; Punit Prakash; Katherine Twombley; Dieter Haemmerich
Journal:  Cancers (Basel)       Date:  2022-03-04       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.